WallStSmart
ATNM

Actinium Pharmaceuticals Inc

NYSE MKT: ATNM · HEALTHCARE · BIOTECHNOLOGY

$1.12
-4.70% today

Updated 2026-04-30

Market cap
$40.16M
P/E ratio
P/S ratio
446.22x
EPS (TTM)
$-1.09
Dividend yield
52W range
$1 – $2
Volume
0.2M

Actinium Pharmaceuticals Inc (ATNM) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-14034.00$-15492.00$-13964.00$-18783.00$7835.00$539.00$-5.21M$-6.29M$-14.35M$-18.54M$-20.79M$-21.55M$-20.57M$-21.46M$-21.62M$-20.87M$8.64M$-47.34M$-33.07M$-24.58M
Capital expenditures$0.00$0.00$0.00$0.00$0.00$0.00$2359.00$16592.00$151688.00$47788.00$59960.00$24739.00$96092.00$63893.00$253000.00$133000.00$366000.00$153000.00$11000.00$104000.00
Depreciation
Stock-based comp$2.22M$657812.00$6.28M$7.06M$4.30M$3.49M$1.80M$1.29M$1.25M$1.69M$2.79M$3.84M$5.29M$9.19M
Free cash flow$-14034.00$-15492.00$-13964.00$-18783.00$7835.00$539.00$-5.22M$-6.31M$-14.50M$-18.59M$-20.85M$-21.58M$-20.67M$-21.53M$-21.87M$-21.00M$8.28M$-47.49M$-33.08M$-24.68M
Investing cash flow
Financing cash flow
Dividends paid$1269.00$1000.00
Share repurchases
Debt repayment
Net change in cash$-85303.00$1.17M$18.94M$-5.12M$-3.12M$-3.69M$-4.41M$54.31M$14.22M